

C4 copy number variation, in addition to HLA and FCGR2B, was found to be a distinct genetic factor associated with IgG4-related disease susceptibility, illustrating the complex polygenic nature of the disease. Furthermore, the identification of PTCH1 and the long non-coding RNA LOC102724227 as Mikulicz's disease-specific susceptibility loci suggests that genetic heterogeneity might underlie the clinical diversity of IgG4-related disease, particularly with respect to the affected organs.
Rheumatology
|31st Dec, 2025
|Journal of the American Medical Association
Rheumatology
|15th Jan, 2026
|The Lancet
Rheumatology
|15th Jan, 2026
|The Lancet
Rheumatology
|15th Jan, 2026
|The Lancet
Rheumatology
|15th Jan, 2026
|The Lancet
Rheumatology
|15th Jan, 2026
|The Lancet
Rheumatology
|15th Jan, 2026
|The Lancet